赫尔格
长QT综合征
机制(生物学)
医学
钾通道
药理学
药品
QT间期
内科学
心脏病学
认识论
哲学
作者
Zeina R. Al Sayed,Céline Pereira,Rémi Le Borgne,Christine Viaris de Lesegno,Charléne Jouve,Esthel Pénard,Adeline Mallet,Nihar Masurkar,Gildas Loussouarn,Jean‐Marc Verbavatz,Christophe Lamaze,David‐Alexandre Trégouët,Jean‐Sébastien Hulot
出处
期刊:Circulation
[Lippincott Williams & Wilkins]
日期:2024-04-29
卷期号:150 (7): 563-576
被引量:2
标识
DOI:10.1161/circulationaha.123.063917
摘要
Drug-induced QT prolongation (diLQT) is a feared side effect that could expose susceptible individuals to fatal arrhythmias. The occurrence of diLQT is primarily attributed to unintended drug interactions with cardiac ion channels, notably the hERG (human ether-a-go-go-related gene) channels that generate the delayed-rectifier potassium current (I
科研通智能强力驱动
Strongly Powered by AbleSci AI